Literature DB >> 19085812

A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants.

Heike Rabe1, Jose R Fernandez Alvarez, Carolyn Lawn, Paul Seddon, Philip N Amess.   

Abstract

Very-low-birth-weight (VLBW) infants often require blood transfusions for anemia. Studies have investigated the preventative effect of delayed cord clamping, high-dose iron, and costly recombinant erythropoietin. As part of our unit clinical governance framework to improving patient care, we audited the effect of a preventative management guideline that combines delayed cord clamping for 30 seconds with early protein intake and early oral iron supplementation (6 mg/kg from days 7 to 10 of life, if milk feeds 60 mL/kg/d) combined with a restrictive transfusion policy in infants < 32 weeks' gestation and < 1500 g birth weight. Data on blood transfusions in VLBW infants during the first 6 weeks of life collected before the start of the new regimen (period I) were compared with data in consecutively born VLBW infants after the introduction of the management guideline (period II). Age (in days) when milk feeds and oral iron supplements were introduced was recorded. Statistical analysis used Wilcoxon signed-rank test. VLBW infants in period I ( N = 18, median birth weight 1001 g [727; 1158]) received a median of four transfusions (0.75; 9) compared with 1.5 (0.75; 5, P = 0.01) VLBW infant transfusions in period II ( N = 22, median birth weight 967 g [792; 1131]). Milk feeds of 60 mL/kg/d were achieved on median day 12 (6; to 16), and iron was introduced on median day 38 (21; to 44) in period I compared with milk feeds on day 9 (7; 15, P = 0.05) and oral iron on day 16 (11; 21, P < 0001) in period II. The combination of a 30-second delay in cord clamping, early protein and iron, and a change of transfusion thresholds reduced the number of blood transfusions by half.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085812     DOI: 10.1055/s-0028-1103024

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  8 in total

Review 1.  Nonpharmacological, blood conservation techniques for preventing neonatal anemia--effective and promising strategies for reducing transfusion.

Authors:  Patrick D Carroll; John A Widness
Journal:  Semin Perinatol       Date:  2012-08       Impact factor: 3.300

Review 2.  Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia.

Authors:  Vivek Saroha; Cassandra D Josephson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2018-12-12       Impact factor: 3.430

3.  A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia.

Authors:  Matthew R Rosebraugh; John A Widness; Demet Nalbant; Peter Veng-Pedersen
Journal:  Transfusion       Date:  2012-10-04       Impact factor: 3.157

4.  Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants.

Authors:  Matthew R Rosebraugh; John A Widness; Demet Nalbant; Gretchen Cress; Peter Veng-Pedersen
Journal:  Pediatr Res       Date:  2013-11-11       Impact factor: 3.756

Review 5.  Research Opportunities to Improve Neonatal Red Blood Cell Transfusion.

Authors:  Ravi Mangal Patel; Erin K Meyer; John A Widness
Journal:  Transfus Med Rev       Date:  2016-07-04

Review 6.  Placental transfusion: may the "force" be with the baby.

Authors:  Judith S Mercer; Debra A Erickson-Owens; Heike Rabe
Journal:  J Perinatol       Date:  2021-04-13       Impact factor: 3.225

Review 7.  Early versus delayed umbilical cord clamping on maternal and neonatal outcomes.

Authors:  Yiyu Qian; Xinxin Ying; Peixin Wang; Zhe Lu; Ying Hua
Journal:  Arch Gynecol Obstet       Date:  2019-06-15       Impact factor: 2.344

Review 8.  Prevention of iron deficiency anemia in infants and toddlers.

Authors:  Sripriya Sundararajan; Heike Rabe
Journal:  Pediatr Res       Date:  2020-04-24       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.